Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Pre-Filled Syringes

27 Jan 2014 - 28 Jan 2014 - London, UK



Bookmark and Share


Registration for Annual Pre-Filled Syringes - 2014 is now open. With one of the most established European market leaders on this subject and the huge successes of their previous meetings, SMi will provide another great forum for new advances in this field. 

Now in its 6th year, the 2014 conference will bring together experts from a range of industry perspectives to discuss solutions and strategies within key issues such as syringe formulations for biosimilars and other biologics, extractables and leachables, primary packaging developments and filling and finishing. 

What’s new in 2014:

•         2 days, 20 speakers, 18 unique presentations;

•         Top-Ranked Speaker Faculty includes leading experts from Pfizer, GlaxoSmithKline, Merck, Boehringer Ingelheim, Ipsen, Roche, Novo Nordisk and many others. 

•         2 panel discussions hosted by Advait Badkar, Bioprocess R&D, Pfizer, Adam Woolley, CEO, ForthTox, Bobbijo Redler, Principal Scientist, Merck, Jason Creasy, Head of Extractables & Leachables Team, GlaxoSmithKline;

•         2 Interactive half-day post-conference workshops: Leachables & Extractables, hosted by Andrew Fieldon, Senior Consultant, Smithers Rapra, and Large Volume Injectors – Technologies, Strategies and Guidance, hosted by Stephen Augustyn, Head of Mechanical Engineering, Team Consulting;

•         £999 (Conference only) for the first 25 pharmaceutical companies;

•         Pre-Filled Syringes – 2014 is proud to be sponsored by BD, Schott, West and Zeon. 

Key reasons to attend:

  Learn about the latest regulatory updates from MHRA and FDA bodies

  Hear exclusive news on autoinjector technologies

  Hear about manufacturing of container integrity and reduction in leachables

  Expand your professional network, meet leading specialists within the industry

  Get a chance to introduce your company and its services to potential partners

 Weblink: www.smi-online.co.uk/2014pfs40.asp

  Organiser: SMi Group Ltd. 

 Contact: Julia Rotar, jrotar@smi-online.co.uk 



Further information
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!